Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $6.43-$42.26 |
Market Cap | $1.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $1.20 |
News
See moreYahoo Finance • 11 days ago
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Yahoo Finance • 11 days ago
QuantumScape rallies as Seeking Alpha analyst pitches the upside
Yahoo Finance • 13 days ago
Rapport Therapeutics prices $250M stock at $26 per share
Yahoo Finance • 13 days ago
Rapport Announces Pricing of Public Offering of Common Stock
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 1325 Boylston Street, Boston, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
